|Retirement reception honors Dr. Ebadi|
A retirement reception in honor of Manuchair (Mike) Ebadi, associate dean for research and program development, is set for 2 to 3:30 p.m. Thursday, May 24, in the Vennes Atrium, School of Medicine and Health Sciences. The program begins at 2 p.m. Everyone is welcome to attend.
Dr. Ebadi, who announced his plans to retire effective June 30, is Chester Fritz Distinguished Professor of Pharmacology and of Clinical Neuroscience and director of the Center of Excellence in Neuroscience. He also holds the titles, senior advisor to the president and associate vice president for medical research.
"We wish to thank Dr. Ebadi for his many contributions to the UND School of Medicine and Health Sciences," said H. David Wilson, dean of the school. "They have been magnificent and magnanimous."
Under his leadership, the research enterprise at the UND medical school has increased sixfold and is due, in large part, to recruitment and support of talented researchers, Wilson said. This year, awards for grants and contracts totaled nearly $20 million, primarily from federal sources, placing the school among the top entities in terms of research activity in the state.
Ebadi also has established awards to recognize outstanding contributions to the field of neuroscience research (Dean H. David Wilson, M.D., Academic Award in Neurosciences), teaching (Hippocratic Dignity Award), and health promotion (Charles E. Kupchella Preventive Medicine and Wellness Award).
Since 1999, Ebadi has served the UND medical school as administrator, faculty member and researcher. An authority in the field of Parkinson's disease, he has written 10 books on subjects related to his field of study, one of which has been translated into Japanese and one into Chinese. He also wrote a reference book on pharmacology, the study of drugs.
He and his colleagues investigate the nature and underlying causes of Parkinson's and other neurodegenerative diseases, as well as drug addiction. A fellow of the American College of Clinical Pharmacology, he conducts research funded by the National Institute of Neurological Diseases and Stroke (NINDS), the National Institute on Aging (NIA) and the Office of National Drug Control Policy which support health-related studies.
-- Shelley Pohlman, Asst. to the Director, Public Affairs, email@example.com, 701-777-4305